These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17651919)

  • 21. Anti-D immunoglobulin in RhD prophylaxis.
    Robson SC; Lee D; Urbaniak S
    Br J Obstet Gynaecol; 1998 Feb; 105(2):129-34. PubMed ID: 9501773
    [No Abstract]   [Full Text] [Related]  

  • 22. Preventing RhD haemolytic disease of the newborn. Women should be counselled about source of anti-D immunoglobulin.
    Saha A
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569418
    [No Abstract]   [Full Text] [Related]  

  • 23. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 24. The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin.
    MacKenzie IZ; Roseman F; Findlay J; Thompson K; Jackson E; Scott J; Reed M
    BJOG; 2006 Jan; 113(1):97-101. PubMed ID: 16398777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RhD immunisation in pregnancy.
    Akkök ÇA; Eggebø TM; Kiserud T; Heier HE
    Tidsskr Nor Laegeforen; 2016 May; 136(8):724-6. PubMed ID: 27143464
    [No Abstract]   [Full Text] [Related]  

  • 26. An audit of the investigation and use of anti-D immunoglobulin prophylaxis in Tayside.
    Rennie I; Smith A; Smith R; Rawlinson PS; Clark P
    Health Bull (Edinb); 2001 May; 59(3):150-4. PubMed ID: 12664753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin.
    Laspina S; O'riordan JM; Lawlor E; Murphy WG
    Vox Sang; 2005 Jul; 89(1):49-51. PubMed ID: 15938740
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-D. Part 2: Risks and benefits.
    Wickham S
    Pract Midwife; 1999 Jun; 2(6):38-9. PubMed ID: 10481677
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antenatal anti-Rh(D) antigen prophylaxis].
    Katsulov A;
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():3-7. PubMed ID: 11785354
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of monoclonal anti-D immunoglobulin in comparison with polyclonal anti-D immunoglobulin in prevention of rho isoimmunization.
    Chauhan AR; Bhattacharyya MS; Turakhia N; Daftary GV
    J Assoc Physicians India; 2002 Oct; 50():1341-2. PubMed ID: 12568238
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
    Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
    [No Abstract]   [Full Text] [Related]  

  • 32. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
    Craig S; Morris K; Tubman T; McClure B
    Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "The use of Rh-immune globulin".
    Lavery JP
    Nebr Med J; 1987 May; 72(5):175-6. PubMed ID: 3035388
    [No Abstract]   [Full Text] [Related]  

  • 34. Cochrane made simple. Anti-D administration during pregnancy for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 Jun; 2(6):10. PubMed ID: 10481667
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-D administration after childbirth for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 May; 2(5):10-1. PubMed ID: 12024602
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of prophylactic anti-D immunoglobin injections.
    Kulkarni SV; Gupte SC; Bhatia HM
    Indian J Med Res; 1987 Feb; 85():181-3. PubMed ID: 3036695
    [No Abstract]   [Full Text] [Related]  

  • 37. A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusion.
    Zeiler T; Wittmann G; Zingsem J; Weisbach V; Zimmermann R; Eckstein R
    Vox Sang; 1994; 66(3):243. PubMed ID: 8036796
    [No Abstract]   [Full Text] [Related]  

  • 38. RCM challenges new anti-D guidelines.
    Pract Midwife; 1999 Nov; 2(10):7. PubMed ID: 12024565
    [No Abstract]   [Full Text] [Related]  

  • 39. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates?
    Atoyebi W; Mundy N; Croxton T; Littlewood TJ; Murphy MF
    Br J Haematol; 2000 Dec; 111(3):980-3. PubMed ID: 11122163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.